NIDA Clinical Trials Network (CTN) Studies of OROS Methylphenidate in Adult ADHD Smokers (Efficacy) and Adolescents with ADHD and Substance Use Disorder (Misuse/Diversion)

Adler, Lenard

Saturday, October 22, 2011 8:30 AM

Lenard Adler, M.D., Psychiatry, Child and Adolescent Psychiatry; Psychiatry Service, New York University School of Medicine; VA New York Harbor Healthcare System, New York, NY

Theresa Winhusen, Ph.D., Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH

Paula D. Riggs, M.D., Psychiatry, Division of Substance Dependence, University of Colorado Denver, Aurora, CO

See more of: Motivation, Stimulant Treatment, and Substance Abuse Risk in ADHD
See more of: Symposium


Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

Symposium Presentation 40.4 NIDA Clinical Trials Network (CTN) Studies of OROS Methylphenidate in Adult ADHD Smokers (Efficacy) and Adolescents with ADHD and Substance Use Disorder (Misuse/Diversion)

Symposium Presentation 40.4
NIDA Clinical Trials Network (CTN) Studies of OROS Methylphenidate in Adult ADHD Smokers (Efficacy) and Adolescents with ADHD and Substance Use Disorder (Misuse/Diversion)